14 results found.

Benign Prostatic Hyperplasia, or Lower Urinary Tract Symptom Clinical Trial using Rezum System; Rigid Cystoscopy

NxThera Inc - Recruiting 50 years or older.
- Minimally Invasive Prostatic Vapor Ablation - Multicenter, Controlled Study for the Treatment of BPH (Rezum II).
Rezum System; Rigid Cystoscopy

Benign Prostatic Hyperplasia Clinical Trial using Prostatic artery embolization; monopolar transurethral prostatectomy

Cantonal Hospital of St. Gallen - Recruiting 40 years or older.
- Prostatic Artery Embolization vs. Conventional Transurethral Prostatectomy in the Treatment of Benign Prostatic Hyperplasia: A Prospective Randomized Trial.
Prostatic artery embolization; monopolar transurethral prostatectomy

Benign Prostatic Hyperplasia Clinical Trial using Embosphere Microspheres; TURP

Merit Medical Systems, Inc. - Recruiting 50 years to 79 years.
- Prospective, Randomized, Controlled Investigation of Prostate Artery Embolization With Embosphere Microspheres Compared to Transurethral Resection of the Prostate for the Treatment of Symptomatic Benign Prostatic Hyperplasia.
Embosphere Microspheres; TURP

Benign Prostatic Hyperplasia (BPH) Requiring Surgical Resection Clinical Trial using Ertapenem

Assistance Publique - H“pitaux de Paris - Recruiting 18 years to 80 years.
- Assessment of Prostatic Tissue Concentration of Ertapenem After a Pre-operative Administration.
Ertapenem

Prostatic Hyperplasia, or Erectile Dysfunction Clinical Trial using 5 mg Tadalafil; Placebo; 0.2 mg Tamsulosin

Eli Lilly and Company - Recruiting 45 years or older.
- A Phase 3, Randomized, Double-Blind, Placebo Controlled, Parallel-Design, Multicenter Study to Evaluate the Efficacy and Safety of Tadalafil Once-Daily Dosing in Men With Signs and Symptoms of Benign Prostatic Hyperplasia and Erectile Dysfunction.
5 mg Tadalafil; Placebo; 0.2 mg Tamsulosin

Benign Prostatic Hyperplasia Clinical Trial using PRX302; Placebo

Sophiris Bio Corp - Recruiting 50 years or older.
- Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of a Single Intraprostatic Treatment of PRX302 for Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (The PLUS 1 Trial).
PRX302; Placebo

Benign Prostate Hyperplasia Clinical Trial using ASP4901; Tamsulosin; Placebo

Astellas Pharma Inc - Recruiting 40 years to 74 years.
- Double-Blind, Placebo-Controlled, Active-Referenced, Parallel-Group Comparative Study in Patients With Benign Prostatic Hyperplasia.
ASP4901; Tamsulosin; Placebo

Neurogenic Lower Urinary Tract Dysfunction Clinical Trial using Naftofidil; Tamsulosin

Samsung Medical Center - Recruiting 20 years to 80 years.
- .
Naftofidil; Tamsulosin

Lower Urinary Tract Symptoms, or Benign Prostatic Hyperplasia Clinical Trial using Transurethral resection of the prostate; Holmium Laser Enucleation of the Prostate

Samsung Medical Center - Recruiting 50 years to 80 years.
- The Comparison of Efficacy Between Holmium Laser Enucleation of the Prostate (HoLEP) and Transurethral Resection of the Prostate (TURP) on the Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostate Hyperplasia (BPH).
Transurethral resection of the prostate; Holmium Laser Enucleation of the Prostate

Benign Prostatic Hyperplasia Clinical Trial

JW Pharmaceutical - Recruiting 50 years or older.
- Observational Study to Evaluate Effect of Thrupasr Capsule on Cardiovascular System in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia.

Benign Prostatic Hyperplasia (BPH) Clinical Trial using Prostate Artery Embolization

Northwestern University - Recruiting 45 years or older.
- Prostatic Artery Embolization (PAE) for Treatment of Signs and Symptoms of Benign Prostatic Hyperplasia (BPH).
Prostate Artery Embolization

Prostatic Hyperplasia Clinical Trial using BONT-A intra-prostatic injection; Optimized medical BPH treatment

University Hospital, Bordeaux - Recruiting 50 years to 85 years.
- Study of the Effectiveness and the Tolerance of Intraprostatic A-botulinic Toxin Injection, in the Treatment of Symptomatic Benign Prostate Hypertrophy..
BONT-A intra-prostatic injection; Optimized medical BPH treatment

Benign Prostatic Hyperplasia Clinical Trial using S-equol; Placebo

Ausio Pharmaceuticals, LLC - Recruiting 50 years or older.
- Randomized, Double Blind, Multicenter, Placebo Controlled, Proof of Concept Trial to Assess the Efficacy and Safety of 4 Weeks Treatment With AUS 131 (S Equol) on Benign Prostatic Hyperplasia.
S-equol; Placebo

Prostate Cancer, Benign Prostatic Hyperplasia, or Enlarged Prosta Clinical Trial using BOTOX

The University of Texas Health Science Center, Houston - Recruiting 50 years or older.
- H-25362: Effect of Botulinum Neurotoxin Type A Prostate Injections on Neurogenesis and Gene Profile Expression in Men With Localized Prostate Cancer and Lower Urinary Tract Symptoms/BPH (Protocol # 05-09-30-03).
BOTOX